-
-
-
-
-
-
-
Prenetics names Brian Rosin as CFO of IM8 health brand
-
-
-
-
-
-
-
Prenetics stops Bitcoin purchases to focus on IM8 supplement brand
-
-
-
-
-
-
-
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
-
-
-
-
-
-
-
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
-
-
-
-
-
-
-
Prenetics Announces First Quarter 2024 Financial Results
-
-
-
-
-
-
-
First Horizon Declares Cash Dividends on Common and Preferred Stock
-
-
-
-
-
-
-
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
-
1,169,827 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

